<?xml version="1.0" encoding="UTF-8"?>
<compound>
  <id type="integer">337139</id>
  <title nil="true"/>
  <common-name>(e)-3-[4-(5-acetyl-3,4-dihydroxyoxolan-2-yl)oxy-3-hydroxyphenyl]-2-methyl-n-(2,3,5,6-tetrahydroxy-4-methoxycyclohexyl)prop-2-enamide</common-name>
  <description>(e)-3-[4-(5-acetyl-3,4-dihydroxyoxolan-2-yl)oxy-3-hydroxyphenyl]-2-methyl-n-(2,3,5,6-tetrahydroxy-4-methoxycyclohexyl)prop-2-enamide is a chemical compound with the formula C23H31NO12. With an average molecular weight of 513.50 g/mol, (e)-3-[4-(5-acetyl-3,4-dihydroxyoxolan-2-yl)oxy-3-hydroxyphenyl]-2-methyl-n-(2,3,5,6-tetrahydroxy-4-methoxycyclohexyl)prop-2-enamide is a heavy molecule.</description>
  <cas>79925-51-2</cas>
  <pubchem-id>6447669</pubchem-id>
  <chemical-formula>C23H31NO12</chemical-formula>
  <weight>513.5</weight>
  <appearance nil="true"/>
  <melting-point nil="true"/>
  <boiling-point nil="true"/>
  <density nil="true"/>
  <solubility nil="true"/>
  <specific-gravity nil="true"/>
  <flash-point nil="true"/>
  <vapour-pressure nil="true"/>
  <route-of-exposure nil="true"/>
  <target nil="true"/>
  <mechanism-of-toxicity nil="true"/>
  <metabolism nil="true"/>
  <toxicity nil="true"/>
  <lethaldose nil="true"/>
  <carcinogenicity nil="true"/>
  <use-source nil="true"/>
  <min-risk-level nil="true"/>
  <health-effects nil="true"/>
  <symptoms nil="true"/>
  <treatment nil="true"/>
  <created-at type="dateTime">2026-08-30T19:51:39Z</created-at>
  <updated-at type="dateTime">2026-08-30T19:51:39Z</updated-at>
  <interacting-proteins nil="true"/>
  <wikipedia nil="true"/>
  <uniprot-id nil="true"/>
  <kegg-compound-id nil="true"/>
  <omim-id nil="true"/>
  <chebi-id nil="true"/>
  <biocyc-id nil="true"/>
  <ctd-id nil="true"/>
  <stitch-id nil="true"/>
  <drugbank-id nil="true"/>
  <pdb-id nil="true"/>
  <actor-id nil="true"/>
  <organism nil="true"/>
  <export type="boolean">true</export>
  <metabolizing-proteins nil="true"/>
  <transporting-proteins nil="true"/>
  <moldb-smiles>CC(=CC1=CC(=C(C=C1)OC2C(C(C(O2)C(=O)C)O)O)O)C(=O)NC3C(C(C(C(C3O)O)OC)O)O</moldb-smiles>
  <moldb-formula>C23H31NO12</moldb-formula>
  <moldb-inchi>InChI=1S/C23H31NO12/c1-8(22(33)24-13-14(27)16(29)21(34-3)17(30)15(13)28)6-10-4-5-12(11(26)7-10)35-23-19(32)18(31)20(36-23)9(2)25/h4-7,13-21,23,26-32H,1-3H3,(H,24,33)/b8-6+</moldb-inchi>
  <moldb-inchikey>LFHKNMMEABAJBZ-SOFGYWHQSA-N</moldb-inchikey>
  <moldb-average-mass type="decimal" nil="true"/>
  <moldb-mono-mass type="decimal">513.1846254</moldb-mono-mass>
  <origin nil="true"/>
  <state nil="true"/>
  <logp>-2.2</logp>
  <hmdb-id nil="true"/>
  <chembl-id nil="true"/>
  <chemspider-id nil="true"/>
  <structure-image-file-name nil="true"/>
  <structure-image-content-type nil="true"/>
  <structure-image-file-size type="integer" nil="true"/>
  <structure-image-updated-at type="dateTime" nil="true"/>
  <biodb-id nil="true"/>
  <synthesis-reference nil="true"/>
  <structure-image-caption nil="true"/>
  <chemdb-id>CHEM333032</chemdb-id>
  <dsstox-id nil="true"/>
  <toxcast-id nil="true"/>
  <stoff-ident-origin nil="true"/>
  <stoff-ident-id nil="true"/>
  <susdat-id nil="true"/>
  <iupac>(e)-3-[4-(5-acetyl-3,4-dihydroxyoxolan-2-yl)oxy-3-hydroxyphenyl]-2-methyl-n-(2,3,5,6-tetrahydroxy-4-methoxycyclohexyl)prop-2-enamide</iupac>
  <moldb-polar-surface-area nil="true"/>
  <moldb-refractivity nil="true"/>
  <moldb-polarizability nil="true"/>
  <moldb-rotatable-bond-count nil="true"/>
  <moldb-acceptor-count nil="true"/>
  <moldb-donor-count nil="true"/>
  <moldb-pka-strongest-acidic nil="true"/>
  <moldb-pka-strongest-basic nil="true"/>
  <moldb-physiological-charge nil="true"/>
  <moldb-number-of-rings nil="true"/>
  <moldb-alogps-logp nil="true"/>
  <moldb-alogps-logs nil="true"/>
  <moldb-alogps-solubility nil="true"/>
  <kingdom>Organic compounds</kingdom>
  <superklass>Organic oxygen compounds</superklass>
  <klass>Organooxygen compounds</klass>
  <subklass>Carbohydrates and carbohydrate conjugates</subklass>
  <paper-count type="integer" nil="true"/>
  <sync-id>CED0287586</sync-id>
  <structure-inchikey>LFHKNMMEABAJBZ-UHFFFAOYSA-N</structure-inchikey>
  <structure-fingerprint>4020800400200000020000000000000010000000000000002200000000000000000000000000000000000000001000000000000000000000000040000000080002000000000000000000000000002080000000038000000080000000000000000001000020004000000010000000000000004000008000000000000050004000004000000000000000000000008000800400000020000000000040000000000000001000000000000008000000000000000000000000010000000010000040000000000000a102000000000000000000000000000001002200000000000000000000000000000040200040000440008002000020000000000000004000</structure-fingerprint>
  <structure-pattern-fingerprint>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</structure-pattern-fingerprint>
  <structure-pickle type="binary" encoding="base64">776t3gAAAAAQAAAAAwAAAAAAAAAkAAAAJgAAAIABBgBgAAAAAQMGACgAAAAD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</structure-pickle>
  <structure-indexed-at type="dateTime">2026-09-19T05:38:20Z</structure-indexed-at>
</compound>
